This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

ACS Webinar focuses on drug discovery process for small molecule therapeutics

April 29th, 2010

News media and others interested in the chemical sciences are invited to join the next in a series of American Chemical Society (ACS) Webinars™, focusing on professional growth and development.

Scheduled for Thursday, May 6, 2 - 3 p.m. EDT, the free ACS Webinars™ will feature Ann Newman, Ph.D., of Seventh Street Development Group, specializing in solid state and pharmaceutical services consulting and training., speaking on "From a Beaker to a Bottle: Overview of the Drug Discovery and Development Process for Small Molecule Therapeutics."

The ACS Webinars™ connect you with subject experts and global thought leaders in chemical sciences, management, and business to addresses current topics of interest to scientific and engineering professionals. Each webinar includes a short presentation followed by a Q & A session.

News media and scientists can tune into the conference without charge, but must register in advance.

Newman's topics will include:


  • The complex scientific and regulatory process needed to get a new drug on the market
  • How long it takes, how much it costs, and the odds of getting one new drug approved
  • The animal trials, clinical trials, and human volunteers needed to test a new drug
  • How generic drugs are approved and the role of patents in the regulatory process

Provided by American Chemical Society

Citation: ACS Webinar focuses on drug discovery process for small molecule therapeutics (2010, April 29) retrieved 19 August 2026 from https://sciencex.com/wire-news/33993490/acs-webinar-focuses-on-drug-discovery-process-for-small-molecule.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.